Trial Details
COMPLETEDBasic Information
| Clinical ID | c1906 |
|---|---|
| Identifier | NCT03262727 |
| Trial Title | The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Systemic Lupus Erythematosus; Arthritic Psoriasis; Psoriasis; Inflammatory Bowel Diseases |
| Interventions | DRUG: BMS-986165; DRUG: Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 μg ethinyl estradiol) |
Participant Information
| Sponsor | Bristol-Myers Squibb |
|---|---|
| City | Miami |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | FEMALE |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2017-09-01 |
|---|---|
| Primary Completion Date | 2017-11-23 |
| Completion Date | 2017-12-19 |